Stay informed about the upcoming IPO of Dr. Agarwal’s Health Care by checking out important details such as the date, review, price, and allotment information.
Dr Agarwal Health Care IPO is set to launch on January 29, 2025, with the closing date scheduled for January 31, 2025. This IPO is classified as a Book Built Issue, aiming to raise approximately ₹3,027.26 crores. The offering includes a fresh issue of ₹300.00 crores and an offer for sale of up to 2,727.26 equity shares with a face value of ₹1 each.
The price band for Dr. Agarwal Health Care IPO is set at ₹382 to ₹402 per share. The allocation for retail investors is 35%, while Qualified Institutional Buyers (QIB) have a 50% allocation and High Net Worth Individuals (HNI) have 15%. The listing of Dr. Agarwals Health Care IPO on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) is expected to take place on February 5, 2025, with the allotment date set for February 3, 2025.
In terms of financial performance, the company reported revenue of ₹1,376.45 crores in 2024, up from ₹1,031.49 crores in 2023. Profits for 2024 were reported at ₹95.05 crores, a slight decrease from ₹103.23 crores in 2023. Based on these financials, potential IPO investors are advised to consider a long-term investment approach.
Dr Agarwal Health Care IPO Details
| IPO Open Date: | January 29, 2025 |
| IPO Close Date: | January 31, 2025 |
| Face Value: | ₹1 Per Equity Share |
| IPO Price Band: | ₹382 to ₹402 Per Share |
| Issue Size: | Approx ₹3,027.26 Crores |
| Fresh Issue: | Approx ₹300 Crores |
| Offer for Sale: | Approx 6,78,42,284 Equity Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
Dr Agarwal Health Care IPO Market Lot
The minimum market lot for the Dr. Agarwal’s Health Care IPO is 35 shares, with an application amount of ₹14,070. Retail investors have the opportunity to apply for up to 13 lots, totaling 490 shares with an amount of ₹1,96,980.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 35 | ₹14,070 |
| Retail Maximum | 13 | 490 | ₹1,96,980 |
| S-HNI Minimum | 14 | 525 | ₹2,11,050 |
| B-HNI Minimum | 68 | 2,520 | ₹10,13,040 |
Dr Agarwal Health Care IPO Dates
The IPO for Dr. Agarwal’s Health Care is scheduled to open on January 29 and close on January 31. The allotment of shares will be finalized on February 3, with the IPO listing set for February 5.
| IPO Open Date: | January 29, 2025 |
| IPO Close Date: | January 31, 2025 |
| Basis of Allotment: | February 3, 2025 |
| Refunds: | February 4, 2025 |
| Credit to Demat Account: | February 4, 2025 |
| IPO Listing Date: | February 5, 2025 |
Promoters of Dr Agarwal Health Care IPO
The founders of the company include a team of esteemed professionals: Dr. Amar Agarwal, Dr. Athiya Agarwal, Dr. Adil Agarwal, Dr. Anosh Agarwal, Dr. Ashvin Agarwal, and Dr. Ashar Agarwal. Additionally, there are family trusts established by each of these individuals to further support the company’s mission. The trusts include Dr. Amar Agarwal Family Trust, Dr. Adil Agarwal Family Trust, Dr. Anosh Agarwal Family Trust, Dr. Ashvin Agarwal Family Trust, and Dr. Ashar Agarwal Family Trust. Furthermore, the company operates under the names Dr. Agarwal’s Eye Institute and Dr. Agarwal’s Eye Institute Private Limited.
About Dr Agarwal’s Health Care IPO
Dr. Agarwal’s Health Care Ltd offers a comprehensive range of eye care services, encompassing refractive, cataract, surgical, and non-surgical treatments. In addition, we provide a variety of opticals, lenses, and other eye care accessories and related products to meet the diverse needs of our patients.
According to a recent CRISIL report, our company holds a significant 25% share in the eye care market as of Fiscal 2024. Throughout the same fiscal year, we successfully treated 2.13 million patients and conducted an impressive 220,523 surgeries. Our commitment to excellence and dedication to providing top-notch eye care services have solidified our position as a leader in the industry.
Dr Agarwal Health Care IPO Company Financial Report
The company reported revenue of ₹1,376.45 crores in 2024 against ₹1,031.49 crore in 2023. The company reported profit of ₹95.05 crores in 2024 against Profit of ₹103.23 crores in 2023.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2022 | ₹713.78 | ₹657.02 | ₹43.16 | ₹1,026.13 |
| 2023 | ₹1,031.49 | ₹947.90 | ₹103.23 | ₹1,825.17 |
| 2024 | ₹1,376.45 | ₹1,235.88 | ₹95.05 | ₹2,752.82 |
| September 2024 | ₹837.94 | ₹777.59 | ₹39.56 | ₹3,393.41 |
Dr AgarwalHealth Care IPO Valuation – FY2024
Please review the detailed Health Care IPO valuations of Dr Agarwal, including metrics such as Earnings Per Share (EPS), Price/Earnings (P/E) Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV).
| KPI | Values |
| ROE: | 3.14% |
| ROCE: | 5.95% |
| EBITDA Margin: | 26.91% |
| PAT Margin: | 4.70% |
| Debt to equity ratio: | 0.70 |
| Earning Per Share (EPS): | ₹3.14 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 6.21% |
| Net Asset Value (NAV): | ₹50.53 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Apollo Hospitals Enterprise Limited | 62.50 | 107.11 | 12.97% | 481.93 | 19,059.20 Cr. |
| Max Healthcare Institute Limited | 10.89 | 95.88 | 12.58% | 86.54 | 6,849.00 Cr. |
| Fortis Healthcare Limited | 7.93 | 82.11 | 7.82% | 101.48 | 6,892.92 Cr. |
| Global Health Limited | 17.80 | 57.49 | 16.46% | 108.17 | 3,275.11 Cr. |
| Narayana Hrudayalaya Limited | 38.86 | 33.14 | 27.37% | 141.98 | 5,018.25 Cr. |
| Krishna Institute of Medical Sciences Limited | 7.75 | 79.79 | 16.96% | 228.47 | 2,498.14 Cr. |
| Aster DM Healthcare Limited | 3.60 | 136.07 | 3.63% | 71.62 | 3,698.90 Cr. |
| Rainbow Children’s Medicare Limited | 21.38 | 67.90 | 17.24% | 124.03 | 1,296.90 Cr. |
Objects of the Issue
Repayment or prepayment, in part or in full, of certain borrowings will be made for general corporate purposes and potential unidentified inorganic acquisitions.
For more market insights, follow our blog.
Stay tuned for more updates and insights on the stock market! For more insights on investing in the Indian stock market, check out resource like ET, NSE India.
Disclaimer: This blog post is for informational purposes only and should not be considered financial advice. Investors should conduct thorough research and consult with a qualified financial advisor before making any investment decisions.